Welcome to the Homepage of

PACT – Platform for Advanced Cellular Therapies


Recap EACTS – PACT Joint Symposium

„Regenerative Medicine: Taking the Science to the Patient“

30th November and 1st December 2017

Vienna, Austria


By the time you read this, we trust that you have returned safe and well to your work place with a motivation and determination to continue your work at least a little, in some aspect, inspired by our joint symposium.


The aim of scientific work in the field of regenerative medicine is to develop devices or novel cell based therapies and derived products that will serve to treat or cure disease-ridden patients. Indeed, to augment and exchange knowledge between groundbreaking fundamental research, the “clinic” and the health agencies that finally approve novel medical devices and novel drug therapies to society. With this in mind, EACTS and PACT joined forces to organize a meeting that brought together basic scientist, clinicians, regulatory affairs and service providers to discuss outlook and progress in regenerative medicine.


Especially in the cardiothoracic field which was the focus of this year’s symposium the “cell centric vision” is under heavy discussion after potential cell based therapies in myocardial infarction have not lived up to the expectations hypothesized by preclinical research. However, novel scientific developments like secretory products derived from cells with regenerative and/or cytoprotective capabilities can now be seen on the horizon of scientific endeavour.


At the Symposium, the excellent quality of the chairs, their session keynotes and speakers with your enthusiasm as participants contributed greatly to make this symposium not only successful but an exhilarating experience. At this point, we would like to thank our Sponsors again very much indeed, since without their support and loyalty such a Symposium would simply not occur. It was also very gratifying to note that so much of the “audience” was students to whom the future of our knowledge belongs and who can continue to develop their skills for patient benefit.


Undoubtedly, cell based therapies will come to the benefit of patients or indeed, cell derived “soups” will develop into “cocktails” or regimes for treatments that will contribute to relieve human and animal disease or suffering.


Finally, we would like to draw your attention to the Book of Abstracts that is available now and the Video Recordings of highlights of this Symposium that will be available by end of January 2018.


“What appears as the impossible is more likely to happen the more often it is attempted” let us continue to work together in “Taking the Science to the Patient”.


Michael Comer, Hendrik Jan Ankersmit, Beatrix Mayer-Reinprecht



EACTS – PACT Joint Symposium

„Regenerative Medicine: Taking the Science to the Patient“

30th November and 1st December 2017

Vienna, Austria


The Steering Group for the Platform for Advanced Cellular Therapies PACT and the European Association for Cardio-Thoracic Surgery EACTS cordially invites you to a Joint-Symposium entitled „Regenerative Medicine: Taking the Science to the Patient“. To reflect on the efforts of the researchers in the field of regenerative medicine and cell based therapies the PACT-Steering Group decided for a Joint Symposium together with EACTS focusing on advances in research and on regulatory issues in respect of Biologicals and ATMPs. Leading authorities in the following areas will deliver keynote lectures, presentations and posters on the subject:


– Infarct Healing as a Therapeutic Target
– Secretome and Regeneration: New Kid on the Block
– ATMPs versus Biologicals
– Regulatory Affairs, GMP-Production and Clinical Trials
– Adipose-derived Mesenchymal Stem Cells in Ischemic Heart Disease

– Human Trials with ATMP-Secretome – from Trachea, Skin and Valve Tissue

– Cellular Plasticity and Tissue Regener
– Inflammation & Immunology
– Micro RNAs as Important Regulators
– Cell and Gene Therapy
– Mechano-Biological Aspects of Cell Behavior



Scientific Programme:



Abstract Submission:

We offer all researchers the opportunity to submit an abstract for the EACTS-PACT Joint Symposium in Vienna. All abstracts will undergo a review process and the best 4 will merit a Young Investigator Nominee Presentation in the official programme.


Please follow all instructions at www.eacts.org, as abstracts will not be accepted unless they are submitted according to the format and instructions described there, and submit your abstract by 1st November 2017 to Registration@Eacts.co.uk.


Poster format: must be A0 portrait


Abstract Book: available here





Registration Fee:

Company Representative     250 €
University Representative    150 €
Students                                  30 € (Student’s ID mandatory)


Fee includes lunch and refreshments on 30 November and 1st December.



Companies interested in collaborating, please contact here. You can present your company during the symposium by exhibiting your products or services.



Marriott – Courtyard Vienna Prater/Messe, Trabrennstraße 4, 1020 Vienna, Austria


WLAN access at the venue



CAT- City Airport Train , Public transport in Vienna


Public Transport
Vienna International Airport – Venue
– Train: Bahnhof Flughafen Wien – Wien Praterstern Bahnhof – then a 20 minute walk to venue

– 1 hour journey

Vienna Central Station – Venue
– Subway U1 + U2 – then a 5 minute walk to venue

– 35 minute journey


Vienna International Airport – Venue
– We encourage you to book a taxi prior to arrival

– 20 minute drive

Vienna Central Station – Venue
– We encourage you to book a taxi prior to arrival
– 15 minute drive

Click here for map



Registration does not include accommodation so please arrange it by yourself.
Hotels in Vienna
Youth Hostels


If you have any questions, don’t hesitate to contact us.

Recap – PACT Summer School 2017

„Primary Cells for Tissue Engineering“


Have you ever isolated stem cells from human fat tissue or the amniotic membrane? Both are human waste materials and are just two topics of this year’s PACT Summer School program. It focused on preparation and propagation of primary cells for tissue engineering purposes, which will lead to applications that hold the potential to bring human and animal therapies from the lab to the clinic.


5 teams of excellent young scientists prepared a challenging program:  In addition to exceptional presentations on the scientific background of cellular development, differentiation and functionality of the envisaged tissue in the body, the appropriate methods and techniques were demonstrated and could be applied in the hands-on courses:


Susanne Wolbank and Eleni Priglinger together with Carolin Steffenhagen, Karin Strohmeier, Julia Maier and Christoph Wurzer isolated stem cells from human adipose tissue.


Asmita Banerjee and Adelheid Weidinger prepared stem cells from the human amniotic membrane and analyzed their mitochondrial activity.


Sylvia Nürnberger and Marian Fürsatz worked on 3D -Pellet culture and biomaterial seeding with cartilage cells.


Wolfgang Holnthoner and Christoph Kaun prepared human endothelial cells from the umbilical cord, performed Matrigel assays and analyzed them by flow cytometry.


Philipp Heher and Janine Tomasch demonstrated the induction of mechanical stimulation of muscle cells-hydrogel constructs.


They all made the program an extraordinary example for perfect transfer of knowledge spanning the broad spectrum from basic science and clinical background to practical skills in the lab.


22 enthusiastic participants from 13 academic institutions of 5 European countries turned out to be hard workers and always followed the lectures and instructions in the lab with dedication. Although the program was rather dense and challenging, they all kept their level of attention until the end of the week and contributed actively to the hands-on sessions.


Despite this dense schedule, the syllabus left enough time for discussions and networking during and between the sessions and at the social events: we had a wonderful dinner at a Viennese Heurigen and had a closing party at the end of our last day with cocktails, cake and cookies!


We would like to thank the teaching teams and all participants for having made this week such a special event!


Here are some of the many positive responses:
“Very valuable experience”

“The course was perfectly organized!”

“Enjoyed it a lot to be a part of it and would like to come back next year”

“This was the best summer school I ever attended and I’m looking forward to coming here again soon, hopefully next year!”

“All instructors were awesome and really at the top of their game!”

“Great topics, great organization … really, really fun and perfect week!”


We cordially welcome our new Institute Member

Center for Translational Medicine (CTM)

International Clinical Research Center 

St. Anne’s University Hospital Brno


St. Anne’s University Hospital Brno
International Clinical Research Center
Pekařská 53
656 91 Brno
Czech Republic



The Center for Translational Medicine (CTM) is a highly interdisciplinary research platform in the International Clinical Research Center (FNUSA-ICRC), a European Union-funded project of the St. Anne’s University Hospital Brno (Czech Republic). The funds so far collected from EU were mostly used to build its own state-of-the-art translational medical research premises. The research center, currently hosts young promising researchers and students from all over the world (9 nationalities represented) and aims at unveiling the molecular mechanisms involved in the onset and progression of the diseases of aging. For this purpose, CTM adopts original and interdisciplinary approaches based on the use of smart materials, microfluidics systems, bioreactors, mechanically-assisted devices and multi-faceted molecular and cellular biology skills to investigate the molecular basis of complex diseases.  more


Inivitation to the

TissueGnostics Symposium „Optics, Algos & Ice“

TissueGnostics is organizing the Optics, Algos and Ice Symposium from 17th to 20th November 2016 in Obergurgl, Tyrol, Austria.


For further information please go to the TissueGnostics website.




Stem Cells‬ for Age-related Macular Degeneration

Nature News: Japanese woman is first recipient of next-generation stem cells. Surgeons implanted retinal tissue created after reverting the patient’s own cells to ‚pluripotent‘ state.